Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3234)
All Articles published online
|
Feb 15, 2010 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deraco M, Baratti D, Cabras AD, Zaffaroni N, Perrone F, Villa R, Jocollè J, Balestra MR, Kusamura S, Laterza B, Pilotti S. Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol 2010; 2(2): 76-84 [PMID: 21160925 DOI: 10.4251/wjgo.v2.i2.76] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v2/i2/76.htm |
| Number | Citing Articles |
| 1 |
Antonio Macrì, Anna Fortugno, Edoardo Saladino. Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. World Journal of Gastrointestinal Oncology 2011; 3(12): 169-174 doi: 10.4251/wjgo.v3.i12.169
|
| 2 |
Aditi Bhatt, Naoual Bakrin, Olivier Glehen. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 253 doi: 10.1007/978-981-10-7053-2_11
|
| 3 |
Marcello Deraco, Dario Baratti, Shigeki Kusamura, Antonello D. Cabras, Federica Perrone, Nadia Zaffaroni. Treatment of Peritoneal Surface Malignancies. Updates in Surgery 2015; : 243 doi: 10.1007/978-88-470-5711-1_17
|
| 4 |
|
| 5 |
Shuang Cai, Taryn R Bagby, M Laird Forrest. Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies. Therapeutic Delivery 2011; 2(11): 1467 doi: 10.4155/tde.11.112
|
| 6 |
Christopher Allen-John Webb, Paul David Weyker, Vivek K. Moitra, Richard K. Raker. An Overview of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for the Anesthesiologist. Anesthesia & Analgesia 2013; 116(4): 924 doi: 10.1213/ANE.0b013e3182860fff
|
| 7 |
Y. Huang, N.A. Alzahrani, W. Liauw, D.L. Morris. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma. European Journal of Surgical Oncology (EJSO) 2015; 41(10): 1373 doi: 10.1016/j.ejso.2015.07.004
|
| 8 |
Wu-yun Wang, Miao-fang Wu, Dong-bing Wu, Li-juan Wang, Hui Li, Zhong-qiu Lin, Jing Li. Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-021-00764-6
|
| 9 |
Shigeki Kusamura, Dario Baratti, Marcello Deraco. Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies. Annals of Surgery 2012; 255(2): 348 doi: 10.1097/SLA.0b013e3182436c28
|
| 10 |
K. Van der Speeten, L. Lemoine. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 79 doi: 10.1007/978-981-10-7053-2_4
|
| 11 |
Ning Jiang, Wei-Quan Zhang, Hong Dong, Ying-Tao Hao, Li-Ming Zhang, Lei Shan, Xiao-Dong Yang, Chuan-Liang Peng. SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family. World Journal of Clinical Cases 2021; 9(19): 5019-5027 doi: 10.12998/wjcc.v9.i19.5019
|
| 12 |
Krishna Pillai, Mohammad Hossein Pourgholami, Terence C. Chua, David Lawson Morris. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. Journal of Cancer Research and Clinical Oncology 2013; 139(6): 987 doi: 10.1007/s00432-013-1408-2
|
| 13 |
Lieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten. Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. International Journal of Hyperthermia 2017; 33(5): 582 doi: 10.1080/02656736.2017.1291999
|
| 14 |
Shigeki Kusamura, Dario Baratti, Ionut Hutanu, Piero Rossi, Marcello Deraco. The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs. Surgical Oncology Clinics of North America 2012; 21(4): 559 doi: 10.1016/j.soc.2012.07.011
|
| 15 |
Kurt Van der Speeten, Lieselotte Lemoine, Paul Sugarbaker. Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura and Peritoneum 2017; 2(2): 63 doi: 10.1515/pp-2017-0003
|
| 16 |
Markus Hirschburger, Winfried Padberg. Induction Chemotherapy. 2016; : 187 doi: 10.1007/978-3-319-28773-7_12
|
| 17 |
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, Marta Recagni, Nadia Zaffaroni, Marco Folini. miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells. Journal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0510-3
|
| 18 |
Tomasz Jastrzębski, Wojciech Zegarski. Przerzuty do otrzewnej raka jelita grubego. Polish Journal of Surgery 2017; 89(5): 34 doi: 10.5604/01.3001.0010.5605
|
| 19 |
Markus Hirschburger, Andreas Hecker, Thilo Schwandner, Winfried Padberg. Regionale Therapie maligner Tumoren. 2013; : 165 doi: 10.1007/978-3-642-35014-6_13
|
| 20 |
Kayomarz Sethna, Shabber Zaveri, Aditi Bhatt. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 221 doi: 10.1007/978-981-10-7053-2_10
|